Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC: Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA. 1999, 96 (16): 9212-9217. 10.1073/pnas.96.16.9212.
CAS
PubMed Central
PubMed
Google Scholar
Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA: Molecular portraits of human breast tumours. Nature. 2000, 406 (6797): 747-752. 10.1038/35021093.
CAS
PubMed
Google Scholar
Cheang MC, van de Rijn M, Nielsen TO: Gene expression profiling of breast cancer. Annu Rev Pathol. 2008, 3: 67-97. 10.1146/annurev.pathmechdis.3.121806.151505.
CAS
PubMed
Google Scholar
Geyer FC, Marchio C, Reis-Filho JS: The role of molecular analysis in breast cancer. Pathology. 2009, 41 (1): 77-88. 10.1080/00313020802563536.
CAS
PubMed
Google Scholar
Sorlie T: Introducing molecular subtyping of breast cancer into the clinic?. J Clin Oncol. 2009, 27 (8): 1153-1154. 10.1200/JCO.2008.20.6276.
PubMed
Google Scholar
Sotiriou C, Pusztai L: Gene-expression signatures in breast cancer. N Engl J Med. 2009, 360 (8): 790-800. 10.1056/NEJMra0801289.
CAS
PubMed
Google Scholar
Bertucci F, Birnbaum D: Reasons for breast cancer heterogeneity. J Biol. 2008, 7 (2): 6-10.1186/jbiol67.
PubMed Central
PubMed
Google Scholar
Miller LD, Liu ET: Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine. Breast Cancer Res. 2007, 9 (2): 206-10.1186/bcr1662.
PubMed Central
PubMed
Google Scholar
Sorlie T, Perou C, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen M, van de Rijn M, Jeffrey S: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences. 2001, 98 (19): 10869-10.1073/pnas.191367098.
CAS
Google Scholar
McShane L, Radmacher M, Freidlin B, Yu R, Li M, Simon R: Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data. 2002, Oxford Univ Press, 18: 1462-1469.
Google Scholar
Suzuki R, Shimodaira H: Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics. 2006, 22 (12): 1540-1542. 10.1093/bioinformatics/btl117.
CAS
PubMed
Google Scholar
Pusztai L, Mazouni C, Anderson K, Wu Y, Symmans WF: Molecular classification of breast cancer: limitations and potential. Oncologist. 2006, 11 (8): 868-877. 10.1634/theoncologist.11-8-868.
CAS
PubMed
Google Scholar
Nowak G, Tibshirani R: Complementary hierarchical clustering. Biostatistics (Oxford, England). 2008, 9 (3): 467-
Google Scholar
Hartigan J: Direct clustering of a data matrix. Journal of the American Statistical Association. 1972, 123-129. 10.2307/2284710.
Google Scholar
Hartigan JA: Clustering algorithms. 1975, New York,: Wiley
Google Scholar
Cheng Y, Church GM: Biclustering of expression data. Proc Int Conf Intell Syst Mol Biol. 2000, 8: 93-103.
CAS
PubMed
Google Scholar
Ben-Dor A, Chor B, Karp R, Yakhini Z: Discovering local structure in gene expression data: the order-preserving submatrix problem. Journal of Computational Biology. 2003, 10 (3-4): 373-384. 10.1089/10665270360688075.
CAS
PubMed
Google Scholar
Tanay A, Sharan R, Shamir R: Discovering statistically significant biclusters in gene expression data. Bioinformatics. 2002, 18 (Suppl 1): S136-S144.
PubMed
Google Scholar
Madeira S, Oliveira A: Biclustering algorithms for biological data analysis: a survey. IEEE Transactions on computational Biology and Bioinformatics. 2004, 24-45. 10.1109/TCBB.2004.2.
Google Scholar
Tanay A, Sharan R, Shamir R: Biclustering algorithms: A survey. Handbook of computational molecular biology. 2005, 9: 26.21-26.17.
Google Scholar
Garey M, Johnson D: Computers and Intractability: A Guide to the Theory of NP-Completeness. 1979, San Francisco: WH Freeman
Google Scholar
Everitt B, Landau S, Less M: Cluster Analysis. 2001, London: Arnold, 4
Google Scholar
Horvath S, Zhang B, Carlson M, Lu K, Zhu S, Felciano R, Laurance M, Zhao W, Qi S, Chen Z: Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proceedings of the National Academy of Sciences. 2006, 103 (46): 17402-10.1073/pnas.0608396103.
CAS
Google Scholar
van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002, 347 (25): 1999-2009. 10.1056/NEJMoa021967.
CAS
PubMed
Google Scholar
Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, Pawitan Y, Hall P, Klaar S, Liu ET: An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA. 2005, 102 (38): 13550-13555. 10.1073/pnas.0506230102.
CAS
PubMed Central
PubMed
Google Scholar
Saldanha AJ: Java Treeview--extensible visualization of microarray data. Bioinformatics. 2004, 20 (17): 3246-3248. 10.1093/bioinformatics/bth349.
CAS
PubMed
Google Scholar
de Hoon M, Imoto S, Nolan J, Miyano S: Open source clustering software. Bioinformatics. 2004, 20 (9): 1453-10.1093/bioinformatics/bth078.
CAS
PubMed
Google Scholar
Pawitan Y, Bjohle J, Amler L, Borg A, Egyhazi S, Hall P, Han X, Holmberg L, Huang F, Klaar S: Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res. 2005, 7 (6): R953-R964. 10.1186/bcr1325.
CAS
PubMed Central
PubMed
Google Scholar
Wang Y, Klijn J, Zhang Y, Sieuwerts A, Look M, Yang F, Talantov D, Timmermans M, Meijer-van Gelder M, Yu J: Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. The Lancet. 2005, 365 (9460): 671-679.
CAS
Google Scholar
Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, Haibe-Kains B, Viale G, Delorenzi M, Zhang Y, d'Assignies MS: Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res. 2007, 13 (11): 3207-3214. 10.1158/1078-0432.CCR-06-2765.
CAS
PubMed
Google Scholar
Gene expression omnibus (GEO): [http://www.ncbi.nlm.nih.gov/geo/]
Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, Sorlie T, Dai H, He YD, van't Veer LJ, Bartelink H: Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA. 2005, 102 (10): 3738-3743. 10.1073/pnas.0409462102. Website companion for, [http://microarray-pubs.stanford.edu/wound_NKI/]
CAS
PubMed Central
PubMed
Google Scholar
Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, Chi JT, van de Rijn M, Botstein D, Brown PO: Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol. 2004, 2 (2): E7-10.1371/journal.pbio.0020007.
PubMed Central
PubMed
Google Scholar
Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, Sorlie T, Dai H, He YD, van't Veer LJ, Bartelink H: Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA. 2005, 102 (10): 3738-3743. 10.1073/pnas.0409462102.
CAS
PubMed Central
PubMed
Google Scholar
Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, Botstein D, Altman R: Missing value estimation methods for DNA microarrays. 2001, Oxford Univ Press, 17: 520-525.
Google Scholar
Sorlie T, Tibshirani R, Parker J, Hastie T, Marron J, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proceedings of the National Academy of Sciences. 2003, 100 (14): 8418-8423. 10.1073/pnas.0932692100.
CAS
Google Scholar
Sotiriou C, Neo S, McShane L, Korn E, Long P, Jazaeri A, Martiat P, Fox S, Harris A, Liu E: Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proceedings of the National Academy of Sciences. 2003, 100 (18): 10393-10398. 10.1073/pnas.1732912100.
CAS
Google Scholar
Bertucci F, Borie N, Ginestier C, Groulet A, Charafe-Jauffret E, Adelaide J, Geneix J, Bachelart L, Finetti P, Koki A: Identification and validation of an ERBB2 gene expression signature in breast cancers. Oncogene. 2004, 23 (14): 2564-2575. 10.1038/sj.onc.1207361.
CAS
PubMed
Google Scholar
Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B: Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst. 2006, 98 (4): 262-272. 10.1093/jnci/djj052.
CAS
PubMed
Google Scholar
Dai H, van't Veer L, Lamb J, He YD, Mao M, Fine BM, Bernards R, van de Vijver M, Deutsch P, Sachs A: A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. Cancer Res. 2005, 65 (10): 4059-4066. 10.1158/0008-5472.CAN-04-3953.
CAS
PubMed
Google Scholar
Bay BH, Jin R, Huang J, Tan PH: Metallothionein as a prognostic biomarker in breast cancer. Exp Biol Med (Maywood). 2006, 231 (9): 1516-1521.
CAS
Google Scholar
Yap X, Tan HY, Huang J, Lai Y, Yip GW, Tan PH, Bay BH: Over-expression of metallothionein predicts chemoresistance in breast cancer. J Pathol. 2009, 217 (4): 563-570. 10.1002/path.2489.
CAS
PubMed
Google Scholar
Ginestier C, Cervera N, Finetti P, Esteyries S, Esterni B, Adelaide J, Xerri L, Viens P, Jacquemier J, Charafe-Jauffret E: Prognosis and gene expression profiling of 20q13-amplified breast cancers. Clin Cancer Res. 2006, 12 (15): 4533-4544. 10.1158/1078-0432.CCR-05-2339.
CAS
PubMed
Google Scholar
Yao J, Weremowicz S, Feng B, Gentleman RC, Marks JR, Gelman R, Brennan C, Polyak K: Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res. 2006, 66 (8): 4065-4078. 10.1158/0008-5472.CAN-05-4083.
CAS
PubMed
Google Scholar
Hodgson JG, Chin K, Collins C, Gray JW: Genome amplification of chromosome 20 in breast cancer. Breast Cancer Res Treat. 2003, 78 (3): 337-345. 10.1023/A:1023085825042.
CAS
PubMed
Google Scholar
Barber RD, Harmer DW, Coleman RA, Clark BJ: GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genomics. 2005, 21 (3): 389-395. 10.1152/physiolgenomics.00025.2005.
CAS
PubMed
Google Scholar
Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004, 351 (27): 2817-2826. 10.1056/NEJMoa041588.
CAS
PubMed
Google Scholar
Paik S: Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen. Oncologist. 2007, 12 (6): 631-635. 10.1634/theoncologist.12-6-631.
CAS
PubMed
Google Scholar
Wang KK, Liu N, Radulovich N, Wigle DA, Johnston MR, Shepherd FA, Minden MD, Tsao MS: Novel candidate tumor marker genes for lung adenocarcinoma. Oncogene. 2002, 21 (49): 7598-7604. 10.1038/sj.onc.1205953.
CAS
PubMed
Google Scholar
Revillion F, Pawlowski V, Hornez L, Peyrat JP: Glyceraldehyde-3-phosphate dehydrogenase gene expression in human breast cancer. Eur J Cancer. 2000, 36 (8): 1038-1042. 10.1016/S0959-8049(00)00051-4.
CAS
PubMed
Google Scholar
Valenti MT, Bertoldo F, Dalle Carbonare L, Azzarello G, Zenari S, Zanatta M, Balducci E, Vinante O, Lo Cascio V: The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene?. BMC Cancer. 2006, 6: 49-10.1186/1471-2407-6-49.
PubMed Central
PubMed
Google Scholar
Pawitan Y, Bjohle J, Amler L, Borg AL, Egyhazi S, Hall P, Han X, Holmberg L, Huang F, Klaar S: Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res. 2005, 7 (6): R953-964. 10.1186/bcr1325.
CAS
PubMed Central
PubMed
Google Scholar
Gao SY, Li EM, Cui L, Lu XF, Meng LY, Yuan HM, Xie JJ, Du ZP, Pang JX, Xu LY: Sp1 and AP-1 regulate expression of the human gene VIL2 in esophageal carcinoma cells. J Biol Chem. 2009, 284 (12): 7995-8004. 10.1074/jbc.M809734200.
CAS
PubMed Central
PubMed
Google Scholar
Wang HJ, Zhu JS, Zhang Q, Sun Q, Guo H: High level of ezrin expression in colorectal cancer tissues is closely related to tumor malignancy. World J Gastroenterol. 2009, 15 (16): 2016-2019. 10.3748/wjg.15.2016.
CAS
PubMed Central
PubMed
Google Scholar
Kobel M, Gradhand E, Zeng K, Schmitt WD, Kriese K, Lantzsch T, Wolters M, Dittmer J, Strauss HG, Thomssen C: Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma. Int J Gynecol Pathol. 2006, 25 (2): 121-130. 10.1097/01.pgp.0000185410.39050.ac.
PubMed
Google Scholar
Elliott BE, Meens JA, SenGupta SK, Louvard D, Arpin M: The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res. 2005, 7 (3): R365-373. 10.1186/bcr1006.
CAS
PubMed Central
PubMed
Google Scholar
Li Q, Wu M, Wang H, Xu G, Zhu T, Zhang Y, Liu P, Song A, Gang C, Han Z: Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells. Cancer Lett. 2008, 261 (1): 55-63. 10.1016/j.canlet.2007.11.018.
CAS
PubMed
Google Scholar
Bruce B, Khanna G, Ren L, Landberg G, Jirstrom K, Powell C, Borczuk A, Keller ET, Wojno KJ, Meltzer P: Expression of the cytoskeleton linker protein ezrin in human cancers. Clin Exp Metastasis. 2007, 24 (2): 69-78. 10.1007/s10585-006-9050-x.
CAS
PubMed
Google Scholar
Boulay P, Cotton M, Melancon P, Claing A: ARF1 controls the activation of the PI3K pathway to regulate EGF dependent growth and migration of breast cancer cells. Journal of Biological Chemistry. 2008, M803603200v803603201
Google Scholar
Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A, Ferno M, Peterson C, Meltzer PS: Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 2001, 61 (16): 5979-5984.
CAS
PubMed
Google Scholar
Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H: FOXA1 expression in breast cancer--correlation with luminal subtype A and survival. Clin Cancer Res. 2007, 13 (15 Pt 1): 4415-4421. 10.1158/1078-0432.CCR-07-0122.
CAS
PubMed
Google Scholar
Thorat MA, Marchio C, Morimiya A, Savage K, Nakshatri H, Reis-Filho JS, Badve S: Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis. J Clin Pathol. 2008, 61 (3): 327-332. 10.1136/jcp.2007.052431.
CAS
PubMed
Google Scholar
Albergaria A, Paredes J, Sousa B, Milanezi F, Carneiro V, Bastos J, Costa S, Vieira D, Lopes N, Lam EW: Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours. Breast Cancer Res. 2009, 11 (3): R40-10.1186/bcr2327.
PubMed Central
PubMed
Google Scholar
Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR: Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell. 2005, 122 (1): 33-43. 10.1016/j.cell.2005.05.008.
CAS
PubMed
Google Scholar
Carroll JS, Brown M: Estrogen receptor target gene: an evolving concept. Mol Endocrinol. 2006, 20 (8): 1707-1714. 10.1210/me.2005-0334.
CAS
PubMed
Google Scholar
Doane AS, Danso M, Lal P, Donaton M, Zhang L, Hudis C, Gerald WL: An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene. 2006, 25 (28): 3994-4008. 10.1038/sj.onc.1209415.
CAS
PubMed
Google Scholar
Wolf I, Bose S, Williamson E, Miller C, Karlan B, Koeffler H: FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer. International journal of cancer. 2007, 120 (5): 10.1002/ijc.22389.
Tomaru Y, Kondo S, Suzuki M, Hayashizaki Y: A comprehensive search for HNF-3alpha-regulated genes in mouse hepatoma cells by 60K cDNA microarray and chromatin immunoprecipitation/PCR analysis. Biochem Biophys Res Commun. 2003, 310 (2): 667-674. 10.1016/j.bbrc.2003.08.148.
CAS
PubMed
Google Scholar
Bi X, Jones T, Abbasi F, Lee H, Stultz B, Hursh DA, Mortin MA: Drosophila caliban, a nuclear export mediator, can function as a tumor suppressor in human lung cancer cells. Oncogene. 2005, 24 (56): 8229-8239. 10.1038/sj.onc.1208962.
CAS
PubMed
Google Scholar
Jung V, Kindich R, Kamradt J, Jung M, Muller M, Schulz WA, Engers R, Unteregger G, Stockle M, Zimmermann R: Genomic and expression analysis of the 3q25-q26 amplification unit reveals TLOC1/SEC62 as a probable target gene in prostate cancer. Mol Cancer Res. 2006, 4 (3): 169-176. 10.1158/1541-7786.MCR-05-0165.
CAS
PubMed
Google Scholar
Haverty PM, Fridlyand J, Li L, Getz G, Beroukhim R, Lohr S, Wu TD, Cavet G, Zhang Z, Chant J: High-resolution genomic and expression analyses of copy number alterations in breast tumors. Genes Chromosomes Cancer. 2008, 47 (6): 530-542. 10.1002/gcc.20558.
CAS
PubMed
Google Scholar
Gelsi-Boyer V, Orsetti B, Cervera N, Finetti P, Sircoulomb F, Rouge C, Lasorsa L, Letessier A, Ginestier C, Monville F: Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol Cancer Res. 2005, 3 (12): 655-667. 10.1158/1541-7786.MCR-05-0128.
CAS
PubMed
Google Scholar
Reyal F, Stransky N, Bernard-Pierrot I, Vincent-Salomon A, de Rycke Y, Elvin P, Cassidy A, Graham A, Spraggon C, Desille Y: Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing co-expressed genes--a study of 130 invasive ductal breast carcinomas. Cancer Res. 2005, 65 (4): 1376-1383. 10.1158/0008-5472.CAN-04-2706.
CAS
PubMed
Google Scholar
Yang ZQ, Streicher KL, Ray ME, Abrams J, Ethier SP: Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Res. 2006, 66 (24): 11632-11643. 10.1158/0008-5472.CAN-06-2946.
CAS
PubMed
Google Scholar
Bernard-Pierrot I, Gruel N, Stransky N, Vincent-Salomon A, Reyal F, Raynal V, Vallot C, Pierron G, Radvanyi F, Delattre O: Characterization of the Recurrent 8p11-12 Amplicon Identifies PPAPDC1B, a Phosphatase Protein, as a New Therapeutic Target in Breast Cancer. Cancer Research. 2008, 68 (17): 7165-10.1158/0008-5472.CAN-08-1360.
CAS
PubMed
Google Scholar
Bertucci F, Finetti P, Cervera N, Charafe-Jauffret E, Mamessier E, Adelaide J, Debono S, Houvenaeghel G, Maraninchi D, Viens P: Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res. 2006, 66 (9): 4636-4644. 10.1158/0008-5472.CAN-06-0031.
CAS
PubMed
Google Scholar
Loi S, Haibe-Kains B, Desmedt C, Wirapati P, Lallemand F, Tutt AM, Gillet C, Ellis P, Ryder K, Reid JF: Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. BMC Genomics. 2008, 9: 239-10.1186/1471-2164-9-239.
PubMed Central
PubMed
Google Scholar
Rody A, Holtrich U, Pusztai L, Liedtke C, Gaetje R, Ruckhaeberle E, Solbach C, Hanker L, Ahr A, Metzler D: T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers. Breast Cancer Res. 2009, 11 (2): R15-10.1186/bcr2234.
PubMed Central
PubMed
Google Scholar
Schmidt M, Bohm D, von Torne C, Steiner E, Puhl A, Pilch H, Lehr HA, Hengstler JG, Kolbl H, Gehrmann M: The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res. 2008, 68 (13): 5405-5413. 10.1158/0008-5472.CAN-07-5206.
CAS
PubMed
Google Scholar
Calabro A, Beissbarth T, Kuner R, Stojanov M, Benner A, Asslaber M, Ploner F, Zatloukal K, Samonigg H, Poustka A: Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer. Breast Cancer Res Treat. 2009, 116 (1): 69-77. 10.1007/s10549-008-0105-3.
CAS
PubMed
Google Scholar
Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A: Stromal gene expression predicts clinical outcome in breast cancer. Nat Med. 2008, 14 (5): 518-527. 10.1038/nm1764.
CAS
PubMed
Google Scholar
Buess M, Nuyten DS, Hastie T, Nielsen T, Pesich R, Brown PO: Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer. Genome Biol. 2007, 8 (9): R191-10.1186/gb-2007-8-9-r191.
PubMed Central
PubMed
Google Scholar
Rønnov-Jessen L, Bissell M: Breast cancer by proxy: can the microenvironment be both the cause and consequence?. Trends in Molecular Medicine. 2009, 15 (1): 5-13. 10.1016/j.molmed.2008.11.001.
PubMed Central
PubMed
Google Scholar
West RB, Nuyten DS, Subramanian S, Nielsen TO, Corless CL, Rubin BP, Montgomery K, Zhu S, Patel R, Hernandez-Boussard T: Determination of stromal signatures in breast carcinoma. PLoS Biol. 2005, 3 (6): e187-10.1371/journal.pbio.0030187.
PubMed Central
PubMed
Google Scholar
West RB, van de Rijn M: Experimental approaches to the study of cancer-stroma interactions: recent findings suggest a pivotal role for stroma in carcinogenesis. Lab Invest. 2007, 87 (10): 967-970. 10.1038/labinvest.3700666.
CAS
PubMed
Google Scholar
Beck AH, Espinosa I, Gilks CB, van de Rijn M, West RB: The fibromatosis signature defines a robust stromal response in breast carcinoma. Lab Invest. 2008, 88 (6): 591-601. 10.1038/labinvest.2008.31.
CAS
PubMed
Google Scholar
Beck AH, Espinosa I, Edris B, Li R, Montgomery K, Zhu S, Varma S, Marinelli RJ, van de Rijn M, West RB: The macrophage colony-stimulating factor 1 response signature in breast carcinoma. Clin Cancer Res. 2009, 15 (3): 778-787. 10.1158/1078-0432.CCR-08-1283.
CAS
PubMed Central
PubMed
Google Scholar
Wang J, Ou ZL, Hou YF, Luo JM, Shen ZZ, Ding J, Shao ZM: Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential. Oncogene. 2006, 25 (54): 7201-7211. 10.1038/sj.onc.1209703.
CAS
PubMed
Google Scholar
Xu L, Ashkenazi A, Chaudhuri A: Duffy antigen/receptor for chemokines (DARC) attenuates angiogenesis by causing senescence in endothelial cells. Angiogenesis. 2007, 10 (4): 307-318. 10.1007/s10456-007-9084-y.
CAS
PubMed
Google Scholar
Bandyopadhyay S, Zhan R, Chaudhuri A, Watabe M, Pai SK, Hirota S, Hosobe S, Tsukada T, Miura K, Takano Y: Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med. 2006, 12 (8): 933-938. 10.1038/nm1444.
CAS
PubMed
Google Scholar
Iiizumi M, Bandyopadhyay S, Watabe K: Interaction of Duffy antigen receptor for chemokines and KAI1: a critical step in metastasis suppression. Cancer Res. 2007, 67 (4): 1411-1414. 10.1158/0008-5472.CAN-06-3801.
CAS
PubMed
Google Scholar
Zijlstra A, Quigley JP: The DARC side of metastasis: shining a light on KAI1-mediated metastasis suppression in the vascular tunnel. Cancer Cell. 2006, 10 (3): 177-178. 10.1016/j.ccr.2006.08.012.
CAS
PubMed
Google Scholar
Miller L, Mason S, Clyde D, McGinniss M: The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. 1976, 295: 302-304.
Google Scholar
Shen H, Schuster R, Stringer KF, Waltz SE, Lentsch AB: The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth. FASEB J. 2006, 20 (1): 59-64. 10.1096/fj.05-4764com.
CAS
PubMed
Google Scholar
Grann V, Ziv E, Joseph C, Neugut A, Wei Y, Jacobson J, Horwitz M, Bowman N, Beckmann K, Hershman D: Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. British Journal of Haematology. 2008, 143 (2): 288-10.1111/j.1365-2141.2008.07335.x.
CAS
PubMed Central
PubMed
Google Scholar
Levy P, Ripoche H, Laurendeau I, Lazar V, Ortonne N, Parfait B, Leroy K, Wechsler J, Salmon I, Wolkenstein P: Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1. Clin Cancer Res. 2007, 13 (2 Pt 1): 398-407. 10.1158/1078-0432.CCR-06-0182.
CAS
PubMed
Google Scholar
Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A: Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004, 6 (1): 17-32. 10.1016/j.ccr.2004.06.010.
CAS
PubMed
Google Scholar
Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, Richardson A, Violette S, Nikolskaya T, Nikolsky Y: Regulation of in situ to invasive breast carcinoma transition. Cancer Cell. 2008, 13 (5): 394-406. 10.1016/j.ccr.2008.03.007.
CAS
PubMed Central
PubMed
Google Scholar
Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR: Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999, 59 (19): 5002-5011.
CAS
PubMed
Google Scholar
Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray J, Carey L, Richardson A, Weinberg R: Reconstruction of functionally normal and malignant human breast tissues in mice. Proceedings of the National Academy of Sciences. 2004, 101 (14): 4966-4971. 10.1073/pnas.0401064101.
CAS
Google Scholar
Bissell M, Radisky D: Putting tumours in context. Nature Reviews Cancer. 2001, 1 (1): 46-54. 10.1038/35094059.
CAS
PubMed Central
PubMed
Google Scholar
Langley R, Fidler I: Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocrine reviews. 2007, 28 (3): 297-10.1210/er.2006-0027.
CAS
PubMed
Google Scholar
Eisen M, Spellman P, Brown P, Botstein D: Cluster analysis and display of genome-wide expression patterns. 1998, National Acad Sciences, 95: 14863-14868.
Google Scholar
Weinstein J, Myers T, O'Connor P, Friend S, Fornace A, Kohn K, Fojo T, Bates S, Rubinstein L, Anderson N: An information-intensive approach to the molecular pharmacology of cancer. Science. 1997, 275 (5298): 343-10.1126/science.275.5298.343.
CAS
PubMed
Google Scholar
Teschendorff AE, Miremadi A, Pinder SE, Ellis IO, Caldas C: An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Genome Biol. 2007, 8 (8): R157-10.1186/gb-2007-8-8-r157.
PubMed Central
PubMed
Google Scholar
Alexe G, Dalgin GS, Scanfeld D, Tamayo P, Mesirov JP, DeLisi C, Harris L, Barnard N, Martel M, Levine AJ: High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates. Cancer Res. 2007, 67 (22): 10669-10676. 10.1158/0008-5472.CAN-07-0539.
CAS
PubMed
Google Scholar